Development of PF-06671008, a Highly Potent Anti-P-Cadherin/Anti-Cd3 Bispecific DART Molecule With Extended Half-Life for the Treatment of Cancer

Antibodies - Switzerland
doi 10.3390/antib5010006

Related search